Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study.
Herbert A ReitsamerVanessa VeraSimon RubenLeon AuJorge Vila-ArteagaMiguel TeusMarkus LenzhoferAndrew ShirlawZhanying BaiMini BalaramIngeborg StalmansPublished in: Acta ophthalmologica (2021)
The gel stent effectively lowered IOP and IOP-lowering medication count over 3 years, with a predictable and acceptable safety profile, when implanted via the traditional ab-interno technique.